Document is current
Any future updates will be listed below
-
Authors
Hansen, I. Schrøder
Aghayan, D. L.
Pelanis, E.
Røsok, B. I.
Brudvik, K. W.
Yaqub, S.
Lassen, K.
Bjørk, I.
Brabrand, K.
Edwin, B.
Syversveen, T.
Fretland, Å. A.
-
Funding
Funding for this research was provided by:
Helse Sør-Øst RHF (2021-065)
University of Oslo
- License Information
-
More Information
Article History
Received: 13 February 2026
Accepted: 26 March 2026
First Online: 14 April 2026
Ethics
Disclosure: Dr. Fretland has the following disclosures: Bayer (speaker), Olympus (speaker), Angiodynamics (speaker), Medtronic (speaker), Siemens Healthineers (institutional). Dr. Røsok has the following disclosures: Amgen (speaker), Eisai (speaker), Astra Zeneca (speaker), Angiodynamics (speaker), Sirtex (speaker). Prof. Edwin has the following disclosures: Medtronic (speaker), Olympus (speaker). Dr. Björk - Paid presentation for GE about the contrast media Sonazoid at Nordic congress of Radiology in May 2025.
